Stay updated on IMRT & Nivolumab for Recurrent Head & Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the IMRT & Nivolumab for Recurrent Head & Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IMRT & Nivolumab for Recurrent Head & Neck Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:33:23.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Added the disease term 'Squamous cell carcinoma of the head and neck' and added the 'Genetic and Rare Diseases Information Center' as a resources entry.
    Difference
    0.2%
    Check dated 2026-04-02T15:23:12.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    Revision history updated: added Revision: v3.5.0 and removed Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T04:56:40.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T00:55:03.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    A new Revision: v3.4.2 was added and the earlier funding-status notice (v3.4.1) was removed; these are administrative site updates that do not affect the trial details or displayed study information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T10:27:37.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Notice added about government funding and operating status; site version updated to v3.4.1, replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T06:23:40.000Z thumbnail image

Stay in the know with updates to IMRT & Nivolumab for Recurrent Head & Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IMRT & Nivolumab for Recurrent Head & Neck Cancer Clinical Trial page.